RISEDRONATE

sanis health inc🇨🇦 Health Canada

Approval Id: 676933d3863bd8ce
Drug Approval Canada Name: RISEDRONATE
Product Name: RISEDRONATE
Status: Marketed
Status Date: 2022-10-05
Original Market Date: 2022-10-05
Din: 02528460
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:24.00
Atc Original: M05BA07 RISEDRONIC ACID
Atc Name: m 05 ba 07
Aig Number: 0135301005
Company Name: sanis health inc
Company Address: 1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5

RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)

150 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

676933d3863bd8ce

Type

Standard